You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 279 No. 13, April 1, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Conflict of Interest
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Disclosure Policies for Gifts From Industry to Academic Faculty

Lisa A. Bero, PhD

JAMA. 1998;279:1031-1032.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The relationships between academic institutions and bioscientific companies are common, complex, and under increasing scrutiny. In this issue of JAMA, Campbell and colleagues1 present the latest article in their series of studies that have explored university-industry relationships. In earlier studies, this group discussed potential conflicts of interest related to receipt of grants and contracts from industry.2-3 About one half of the companies surveyed in these previous studies supported research at universities through grants.2 In their present article, Campbell and colleagues report on gifts received by faculty at 50 universities. Types of gifts include discretionary funds, biomaterials, support for students, research equipment, and trips to professional meetings.1 Almost half of the faculty surveyed received gifts. The faculty perceived that these gifts were frequently accompanied by restrictions, including prepublication review of manuscripts and loss of university patent rights. Considering that gifts are often not subjected to the . . . [Full Text of this Article]

From the Department of Clinical Pharmacy, Institute for Health Policy Studies, San Francisco Cochrane Center, and the Chancellor's Advisory Panel on Relations With Industry, University of California, San Francisco.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Looking a Gift Horse in the Mouth: Corporate Gifts Supporting Life Sciences Research
Eric G. Campbell, Karen Seashore Louis, and David Blumenthal
JAMA. 1998;279(13):995-999.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Symposium. Relationships with Industry: Critical for New Technology or an Unnecessary Evil?
Jacobs et al.
JBJS 2006;88:1650-1663.
FULL TEXT  

Implementation Of Financial Disclosure Policies To Manage Conflicts Of Interest
Boyd et al.
Health Aff (Millwood) 2004;23:206-214.
ABSTRACT | FULL TEXT  

Supporting whistleblowers in academic medicine: training and respecting the courage of professional conscience
Faunce et al.
J. Med. Ethics 2004;30:40-43.
ABSTRACT | FULL TEXT  

Corporate Gifts to Academic Researchers
Hsu et al.
JAMA 1998;280:883-884.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.